0
0
12/3/23 at 8:00am
Organization
Cancertherapyadvisor.com
Author
Julie Ehlers
34 words
0
Comments
Researchers have found that genomic risk distribution can vary widely across clinical stage groups among patients with prostate cancer.
You are the first to view
https://www.cancertherapyadvisor.com/home/news/conference-coverage/suo-2023/genomic-clinicopathologic-risk-groups-prognostication-prostate-cancer/
Create an account
or login to join the discussion